News

Over the last three decades, colorectal cancer survival in the United States has improved significantly. But in young people incidence and mortality due to colorectal cancer are on the rise. Even among patients with early-stage colorectal cancer, racial disparities have grown more pronounced, with survival after colorectal cancer diagnosis poorer among African Americans compared with whites. Charles R. Rogers, PhD, MPH, MS, is working to better understand these factors in young people with colorectal cancer in order to help improve outcomes and reduce related disparities from this preventable disease.

Construction at the Senator Orrin G. Hatch Center for Proton Therapy at Huntsman Cancer Institute is well underway. On March 28, a 15-ton proton accelerator arrived and was installed at the future center. This marks a major milestone for the project slated for a December 2020 debut.

The PathMaker Program definitely had a significant impact on my career path. It was what opened the door to the research world and provided me with the support I needed even after completing the program. I learned that even though my internship ended, the relationships and contacts I gained in the program did not. PathMaker has helped me in every step of my career, and I will be forever grateful.

Todos los días en Huntsman Cancer Institute (HCI, por sus siglas en inglés), los miembros de nuestros más de 200 equipos de investigación del cáncer entran por la puerta con un fuerte sentido de responsabilidad para marcar la diferencia en los desafíos que enfrentamos respecto al cáncer. Traen experiencia de todo el mundo y son reconocidos por su colaboración excepcional.

Every day at Huntsman Cancer Institute (HCI), members of our more than 200 cancer research teams enter the doors with a strong sense of responsibility to make a difference in the cancer challenges we face. They bring expertise from all over the world and are recognized for their exceptional collaboration.

Huntsman Cancer Institute has established The Society of Huntsman Translational Scholars, an initiative that recognizes excellence in the discipline of translational science. Courtney Scaife, MD, was recently honored with a Huntsman Translational Scholar award.

Huntsman Cancer Institute has established The Society of Huntsman Translational Scholars, an initiative that recognizes excellence in the discipline of translational science. Benjamin L. Maughan, MD, PharmD, was recently honored with a Huntsman Translational Scholar award.

To say that the PathMaker Program made an impact on my life would be a huge understatement. I learned so much from my PathMaker experience, I honestly could write a book about it. Because of the skills I learned, the connections I made, and the amazing mentorship I received, the program instilled in me a drive to continue to chase my dreams.